SGLT2 inhibitors × kidney outcomes

SynthesisRenal failure2023

Comparative efficacy and safety of sodium-glucose cotransporter 2 inhibitors for renal outcomes in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis.

Junhua Ma et al.PubMed ↗Full text ↗Publisher ↗

What moved togetherboth groups pooled, not the treatment’s effect

Correlation · may be no link

No clear link with kidney outcomes

−12%−32% to +15%

Bigger than 3 in 10 on the map

As reported

RR 0.88, 95% CI 0.68–1.15

One number in the abstract

the abstract, start to end

with the risk of renal impairment (RR = 0.88, 95%CI = 0.68-1.15,

← favours treatmentfavours comparator →
could be chance
Kidney outcomes
RR 0.880.68–1.15
SGLT2 inhibitorsKidney outcomes
1 / 3

4 papers cite it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37724571